JUPITER NEUROSCIENCES, INC. 8-K

What Happened
Jupiter Neurosciences, Inc. filed an 8‑K reporting that on June 5, 2026 it amended Alison Silva’s employment agreement to appoint her Chief Operating Officer and President and to raise her base salary to $340,200 (from $315,000). The Board (on the recommendation of the Compensation Committee) approved multiple stock option awards on June 2, 2026 to recognize contributions and in lieu of cash bonuses for executives and to compensate independent directors.

Key Details

• Alison Silva: base salary increased to $340,200 (from $315,000); one-time option grant to purchase up to 600,000 shares under the 2025 Equity Incentive Plan (exercise price = Nasdaq closing price on grant date). Separately, Silva was also awarded 427,304 options as a discretionary bonus in lieu of cash.
• Executive discretionary option awards (in lieu of cash): Christer Rosén (Chairman & CEO) 747,783 options; Saleem Elmasri (CFO) 325,565 options; Marshall Hayward, Ph.D. (CSO & Director) 259,231 options; Alexander Rosén (CAO) 341,843 options.
• Additional grant: the Board approved a one‑time grant of 200,000 options to Saleem Elmasri to recognize his contributions.
• Director awards: each independent non‑employee director received an option grant to purchase up to 100,000 shares.
• Vesting and exercise: all noted option grants vest over three years beginning September 2, 2026 in equal quarterly installments, subject to continued service; exercise prices equal the Nasdaq closing price on the respective grant dates.

Why It Matters
This filing documents leadership change and compensation actions that affect corporate governance and management incentives. Silva’s promotion and salary increase signal a formal elevation in operational leadership. The sizable option grants to executives and directors may increase future share dilution if exercised and will be reflected as share‑based compensation expense in future financial reports. The three‑year vesting schedule ties awards to continued service, reflecting retention and performance alignment rather than immediate cash payouts.